Oscotec Inc.

Translating science into medicine
Sign Up
  1. Lazertinib Shows Promising Antitumor Activity in Patients With EGFR+ NSCLC

    Date2019-12-14 MediaTargeted Oncology PipelineLazertinib
    Read More
  2. Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study

    Date2019-11-04 MediaTHE LANCET ONCOLOGY PipelineLazertinib
    Read More
  3. Korea`s Yuhan Licenses out Lung Cancer Treatment to Janssen Biotech

    Date2018-11-05 MediaBusinessKorea PipelineLazertinib
    Read More
  4. Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring Exon 20 Insertion Mutations

    Date2020-05-18 MediaBioSpace PipelineLazertinib
    Read More
  5. IPOs spawn instant billionaires

    Date2007-02-20 MediaThe Korea Herald PipelineOscotec
    Read More
  6. INTERVIEW: Oscotec Lays Out Global Ambitions For RA, Cancer Drugs

    Date2016-08-23 MediaScrip (Informa Pharma Intelligence) PipelineOscotec
    Read More
  7. Genosco/Yuhan Announce Results from Phase 1/2 Study of YH25448, a 3rd-Generation EGFR-TKI, in Advanced NSCLC to be Presented at ASCO 2018

    Date2018-05-16 MediaBusinesswire PipelineLazertinib
    Read More
  8. Genosco gears up for IPO

    Date2019-01-28 MediaTHE INVESTOR PipelineGenosco
    Read More
  9. G-749, a novel FLT3 Kinase inhibitor, can overcome drug resistance for the treatment of acute myeloid leukemia.

    Date2014-04-03 MediaPubMed PipelineSKI-G-801
    Read More
  10. AXL receptor tyrosine kinase as a promising anti-cancer approach: functions, molecular mechanisms and clinical applications

    Date2019-11-04 MediaMolecular Cancer PipelineSKI-G-801
    Read More
  11. Abstract 2010 : SKI-G-801, an AXL kinase inhibitor, blocks metastasis and induces anti-tumor immune response in various syngeneic cancer models

    Date2019-07-01 MediaCANCER RESEARCH PipelineSKI-G-801
    Read More
  12. "Global Immune Thrombocytopenia (ITP) Market Insights, Epidemiology, and Forecasts, 2017-2028 : Focus on United States, Germany, Spain, Italy, France, and the United Kingdom, and Japan"

    Date2019-12-02 MediaPRNewswire PipelineGenosco
    Read More
Board Pagination Prev 1 2 3 Next
/ 3
© k2s0o1d6e0s8i2g7n. ALL RIGHTS RESERVED.
Requesting to the server, please wait.